Management ChangeApr 15, 2026, 06:12 AM
Structure Therapeutics Appoints Matthew Lang as COO & General Counsel
AI Summary
Structure Therapeutics Inc. announced the appointment of Matthew Lang as its Chief Operating Officer and General Counsel, effective April 15, 2026. Mr. Lang brings extensive experience from previous leadership roles at biopharmaceutical companies such as Metsera, Lyell Immunopharma, Myovant Sciences, and Gilead Sciences. His appointment is expected to strengthen the company's operational and legal leadership.
Key Highlights
- Matthew Lang appointed Chief Operating Officer and General Counsel.
- Appointment effective April 15, 2026.
- Lang previously served as Chief Legal Officer at Metsera from April 2025 to February 2026.
- Held executive roles at Lyell Immunopharma, Myovant Sciences, and Gilead Sciences.
Price Impact
More from GPCR